Efficacy of Chloroquine or Hydroxychloroquine in Treating Pneumonia Caused by SARS-Cov-2 - COVID-19
Status:
Completed
Trial end date:
2020-09-03
Target enrollment:
Participant gender:
Summary
Facing the challenge of finding an efficient treatment for COVID-19, the viral pneumonia
caused by the Coronavirus SARS-Cov-2, this study intended to test if Chloroquine or
Hydroxychloroquine, two drugs with strong in-vitro antiviral role proven by numerous studies
and with a well defined safety profile established, for efficacy in treating COVID-19 and
improving an ordinal primary outcome composed by a 9-levels scale, which was recomended by
the World Health Organization.
Phase:
Phase 3
Details
Lead Sponsor:
Centro de Estudos e Pesquisa em Emergencias Medicas e Terapia Intensiva